BOCCUTO, ADELE
BOCCUTO, ADELE
Dipartimento di Biotecnologie Mediche
Agreement between an in-house replication competent and a reference replication defective recombinant virus assay for measuring phenotypic resistance to HIV-1 protease, reverse transcriptase, and integrase inhibitors
2018-01-01 Saladini, Francesco; Giannini, Alessia; Boccuto, Adele; Vicenti, Ilaria; Zazzi, Maurizio
Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIβ) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus and Human Rhinoviruses
2021-01-01 Martina, Maria Grazia; Vicenti, Ilaria; Bauer, Lisa; Crespan, Emmanuele; Rango, Enrico; Boccuto, Adele; Olivieri, Noemi; Incerti, Matteo; Zwaagstra, Marleen; Allodi, Marika; Bertoni, Simona; Dreassi, Elena; Zazzi, Maurizio; van Kuppeveld, Frank J M; Maga, Giovanni; Radi, Marco
BNT162b2 SARS-CoV-2 vaccination elicits high titers of neutralizing antibodies to both b.1 and p.1 variants in previously infected and uninfected subjects
2021-01-01 Vicenti, I.; Gatti, F.; Scaggiante, R.; Boccuto, A.; Zago, D.; Basso, M.; Dragoni, F.; Parisi, S. G.; Zazzi, M.
Comparable in vitro activity of second-generation HIV-1 integrase strand transfer inhibitors (INSTIs) on HIV-1 clinical isolates with INSTI resistance mutations
2020-01-01 Saladini, Francesco; Giannini, Alessia; Boccuto, Adele; Dragoni, Filippo; Appendino, Alice; Albanesi, Edoardo; Vicenti, Ilaria; Zazzi, Maurizio
Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro
2018-01-01 Vicenti, Ilaria; Boccuto, Adele; Giannini, Alessia; Dragoni, Filippo; Saladini, Francesco; Zazzi, Maurizio
DDX3X inhibitors, an effective way to overcome HIV-1 resistance
2020-01-01 Brai, Annalaura; Riva, Valentina; Saladini, Francesco; Zamperini, Claudio; Trivisani, CLAUDIA IMMACOLATA; Garbelli, Anna; Pennisi, Carla; Giannini, Alessia; Boccuto, Adele; Bugli, Francesca; Martini, Maurizio; Sanguinetti, Maurizio; Dreassi, Elena; Zazzi, Maurizio; Maga, Giovanni; Botta, Maurizio
Decreased neutralization of the Eta SARS-CoV-2 variant by sera of previously infected and uninfected vaccinated individuals
2021-01-01 Boccuto, A.; Dragoni, F.; Bergna, A.; Ventura, C. D.; Giammarino, F.; Saladini, F.; Pezzati, L.; Zehender, G.; Zazzi, M.; Vicenti, I.; Lai, A.
Development of a Cell-Based Immunodetection Assay for Simultaneous Screening of Antiviral Compounds Inhibiting Zika and Dengue Virus Replication.
2020-01-01 Vicenti, I; Dragoni, F; Giannini, A; Giammarino, F; Spinicci, M; Saladini, F; Boccuto, A; Zazzi, M.
Development of an internally controlled quantitative PCR to measure total cell-associated HIV-1 DNA in blood
2018-01-01 Vicenti, Ilaria; Meini, Genny; Saladini, Francesco; Giannini, Alessia; Boccuto, Adele; Schiaroli, Elisabetta; Zazzi, Maurizio
Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro.
2020-01-01 Dragoni, F; Boccuto, A; Picarazzi, F; Giannini, A; Giammarino, F; Saladini, F; Mori, M; Mastrangelo, E; Zazzi, M; Vicenti, I.
Exploring the implication of DDX3X in DENV infection: discovery of the first-in-class DDX3X fluorescent inhibitor
2020-01-01 Brai, Annalaura; Boccuto, Adele; Monti, Martina; Marchi, Serena; Vicenti, Ilaria; Saladini, Francesco; Trivisani, CLAUDIA IMMACOLATA; Pollutri, Alessandro; Trombetta, CLAUDIA MARIA; Montomoli, Emanuele; Riva, Valentina; Garbelli, Anna; Maria Nola, Emanuele; Zazzi, Maurizio; Maga, Giovanni; Dreassi, Elena; Botta, Maurizio
Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose
2021-01-01 Vicenti, Ilaria; Basso, Monica; Gatti, Francesca; Scaggiante, Renzo; Boccuto, Adele; Zago, Daniela; Modolo, Eliana; Dragoni, Filippo; Parisi, Saverio Giuseppe; Zazzi, Maurizio
In vitro anti-sars-cov-2 activity of selected metal compounds and potential molecular basis for their actions based on computational study
2021-01-01 Cirri, D.; Marzo, T.; Tolbatov, I.; Marrone, A.; Saladini, F.; Vicenti, I.; Dragoni, F.; Boccuto, A.; Messori, L.
In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring multiple NNRTI resistance mutations
2021-01-01 Saladini, F.; Giammarino, F.; Hosseini, B. A.; Giannini, A.; Boccuto, A.; Dragoni, F.; Vicenti, I.; Shafer, R. W.; Zazzi, M.
In vitro susceptibility of HIV-1 CRF02_AG to temsavir, the active compound of the attachment inhibitor fostemsavir
2021-01-01 Saladini, Francesco; Giannini, Alessia; Giammarino, Federica; Boccuto, Adele; Dragoni, Filippo; Vicenti, Ilaria; Zazzi, Maurizio
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells
2021-01-01 Vicenti, Ilaria; Dragoni, Filippo; Monti, Martina; Trombetta, Claudia Maria; Giannini, Alessia; Boccuto, Adele; Saladini, Francesco; Rossetti, Barbara; De Luca, Andrea; Ciabattini, Annalisa; Pastore, Gabiria; Medaglini, Donata; Orofino, Giancarlo; Montomoli, Emanuele; Zazzi, Maurizio
Neutralizing activity of African lineage Zika virus immune sera towards Asian lineage
2023-01-01 Marchi, Serena; Dragoni, Filippo; Boccuto, Adele; Idoko, Olubukola T; Zazzi, Maurizio; Sow, Samba; Aldiouma, Diallo; Viviani, Simonetta; Montomoli, Emanuele; Vicenti, Ilaria; Trombetta, Claudia Maria
Novel antiviral strategies against emerging viral diseases
2020-01-01 Boccuto, A.
Performance of Geno2Pheno[coreceptor] to infer coreceptor use in human immunodeficiency virus type 1 (HIV-1) subtype A
2019-01-01 Vicenti, I.; Lai, A.; Giannini, A.; Boccuto, A.; Dragoni, F.; Saladini, F.; Zazzi, M.
Piperazine-derived small molecules as potential Flaviviridae NS3 protease inhibitors. In vitro antiviral activity evaluation against Zika and Dengue viruses
2023-01-01 del Rosario Garcia-Lozano, M.; Dragoni, F.; Gallego, P.; Mazzotta, S.; Lopez-Gomez, A.; Boccuto, A.; Martinez-Cortes, C.; Rodriguez-Martinez, A.; Perez-Sanchez, H.; Manuel Vega-Perez, J.; Antonio Del Campo, J.; Vicenti, I.; Vega-Holm, M.; Iglesias-Guerra, F.
| Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
|---|---|---|---|---|
| Agreement between an in-house replication competent and a reference replication defective recombinant virus assay for measuring phenotypic resistance to HIV-1 protease, reverse transcriptase, and integrase inhibitors | 1-gen-2018 | Saladini, Francesco; Giannini, Alessia; Boccuto, Adele; Vicenti, Ilaria; Zazzi, Maurizio | - | |
| Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIβ) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus and Human Rhinoviruses | 1-gen-2021 | Martina, Maria Grazia; Vicenti, Ilaria; Bauer, Lisa; Crespan, Emmanuele; Rango, Enrico; Boccuto, Adele; Olivieri, Noemi; Incerti, Matteo; Zwaagstra, Marleen; Allodi, Marika; Bertoni, Simona; Dreassi, Elena; Zazzi, Maurizio; van Kuppeveld, Frank J M; Maga, Giovanni; Radi, Marco | - | |
| BNT162b2 SARS-CoV-2 vaccination elicits high titers of neutralizing antibodies to both b.1 and p.1 variants in previously infected and uninfected subjects | 1-gen-2021 | Vicenti, I.; Gatti, F.; Scaggiante, R.; Boccuto, A.; Zago, D.; Basso, M.; Dragoni, F.; Parisi, S. G.; Zazzi, M. | - | |
| Comparable in vitro activity of second-generation HIV-1 integrase strand transfer inhibitors (INSTIs) on HIV-1 clinical isolates with INSTI resistance mutations | 1-gen-2020 | Saladini, Francesco; Giannini, Alessia; Boccuto, Adele; Dragoni, Filippo; Appendino, Alice; Albanesi, Edoardo; Vicenti, Ilaria; Zazzi, Maurizio | - | |
| Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro | 1-gen-2018 | Vicenti, Ilaria; Boccuto, Adele; Giannini, Alessia; Dragoni, Filippo; Saladini, Francesco; Zazzi, Maurizio | - | |
| DDX3X inhibitors, an effective way to overcome HIV-1 resistance | 1-gen-2020 | Brai, Annalaura; Riva, Valentina; Saladini, Francesco; Zamperini, Claudio; Trivisani, CLAUDIA IMMACOLATA; Garbelli, Anna; Pennisi, Carla; Giannini, Alessia; Boccuto, Adele; Bugli, Francesca; Martini, Maurizio; Sanguinetti, Maurizio; Dreassi, Elena; Zazzi, Maurizio; Maga, Giovanni; Botta, Maurizio | - | |
| Decreased neutralization of the Eta SARS-CoV-2 variant by sera of previously infected and uninfected vaccinated individuals | 1-gen-2021 | Boccuto, A.; Dragoni, F.; Bergna, A.; Ventura, C. D.; Giammarino, F.; Saladini, F.; Pezzati, L.; Zehender, G.; Zazzi, M.; Vicenti, I.; Lai, A. | - | |
| Development of a Cell-Based Immunodetection Assay for Simultaneous Screening of Antiviral Compounds Inhibiting Zika and Dengue Virus Replication. | 1-gen-2020 | Vicenti, I; Dragoni, F; Giannini, A; Giammarino, F; Spinicci, M; Saladini, F; Boccuto, A; Zazzi, M. | - | |
| Development of an internally controlled quantitative PCR to measure total cell-associated HIV-1 DNA in blood | 1-gen-2018 | Vicenti, Ilaria; Meini, Genny; Saladini, Francesco; Giannini, Alessia; Boccuto, Adele; Schiaroli, Elisabetta; Zazzi, Maurizio | - | |
| Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro. | 1-gen-2020 | Dragoni, F; Boccuto, A; Picarazzi, F; Giannini, A; Giammarino, F; Saladini, F; Mori, M; Mastrangelo, E; Zazzi, M; Vicenti, I. | - | |
| Exploring the implication of DDX3X in DENV infection: discovery of the first-in-class DDX3X fluorescent inhibitor | 1-gen-2020 | Brai, Annalaura; Boccuto, Adele; Monti, Martina; Marchi, Serena; Vicenti, Ilaria; Saladini, Francesco; Trivisani, CLAUDIA IMMACOLATA; Pollutri, Alessandro; Trombetta, CLAUDIA MARIA; Montomoli, Emanuele; Riva, Valentina; Garbelli, Anna; Maria Nola, Emanuele; Zazzi, Maurizio; Maga, Giovanni; Dreassi, Elena; Botta, Maurizio | - | |
| Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose | 1-gen-2021 | Vicenti, Ilaria; Basso, Monica; Gatti, Francesca; Scaggiante, Renzo; Boccuto, Adele; Zago, Daniela; Modolo, Eliana; Dragoni, Filippo; Parisi, Saverio Giuseppe; Zazzi, Maurizio | - | |
| In vitro anti-sars-cov-2 activity of selected metal compounds and potential molecular basis for their actions based on computational study | 1-gen-2021 | Cirri, D.; Marzo, T.; Tolbatov, I.; Marrone, A.; Saladini, F.; Vicenti, I.; Dragoni, F.; Boccuto, A.; Messori, L. | - | |
| In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring multiple NNRTI resistance mutations | 1-gen-2021 | Saladini, F.; Giammarino, F.; Hosseini, B. A.; Giannini, A.; Boccuto, A.; Dragoni, F.; Vicenti, I.; Shafer, R. W.; Zazzi, M. | - | |
| In vitro susceptibility of HIV-1 CRF02_AG to temsavir, the active compound of the attachment inhibitor fostemsavir | 1-gen-2021 | Saladini, Francesco; Giannini, Alessia; Giammarino, Federica; Boccuto, Adele; Dragoni, Filippo; Vicenti, Ilaria; Zazzi, Maurizio | - | |
| Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells | 1-gen-2021 | Vicenti, Ilaria; Dragoni, Filippo; Monti, Martina; Trombetta, Claudia Maria; Giannini, Alessia; Boccuto, Adele; Saladini, Francesco; Rossetti, Barbara; De Luca, Andrea; Ciabattini, Annalisa; Pastore, Gabiria; Medaglini, Donata; Orofino, Giancarlo; Montomoli, Emanuele; Zazzi, Maurizio | - | |
| Neutralizing activity of African lineage Zika virus immune sera towards Asian lineage | 1-gen-2023 | Marchi, Serena; Dragoni, Filippo; Boccuto, Adele; Idoko, Olubukola T; Zazzi, Maurizio; Sow, Samba; Aldiouma, Diallo; Viviani, Simonetta; Montomoli, Emanuele; Vicenti, Ilaria; Trombetta, Claudia Maria | - | |
| Novel antiviral strategies against emerging viral diseases | 1-gen-2020 | Boccuto, A. | - | |
| Performance of Geno2Pheno[coreceptor] to infer coreceptor use in human immunodeficiency virus type 1 (HIV-1) subtype A | 1-gen-2019 | Vicenti, I.; Lai, A.; Giannini, A.; Boccuto, A.; Dragoni, F.; Saladini, F.; Zazzi, M. | - | |
| Piperazine-derived small molecules as potential Flaviviridae NS3 protease inhibitors. In vitro antiviral activity evaluation against Zika and Dengue viruses | 1-gen-2023 | del Rosario Garcia-Lozano, M.; Dragoni, F.; Gallego, P.; Mazzotta, S.; Lopez-Gomez, A.; Boccuto, A.; Martinez-Cortes, C.; Rodriguez-Martinez, A.; Perez-Sanchez, H.; Manuel Vega-Perez, J.; Antonio Del Campo, J.; Vicenti, I.; Vega-Holm, M.; Iglesias-Guerra, F. | - |